Amplia Therapeutics Limited (ASX:ATX)

Amplia Therapeutics Revenue

In the fiscal year ending March 31, 2026, Amplia Therapeutics had annual revenue of 5.49M AUD with 45.10% growth. Amplia Therapeutics had revenue of 2.63M in the half year ending September 30, 2025, with 7.44% growth.

• Revenue: 5.49M
• Revenue Growth: +35.25%
• P/S Ratio: 12.62
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 69.26M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	5.49M	1.71M	45.10%
Mar 31, 2025	3.78M	-669.04K	-15.03%
Mar 31, 2024	4.45M	3.26M	274.34%
Mar 31, 2023	1.19M	-793.83K	-40.03%
Mar 31, 2022	1.98M	449.80K	29.33%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 30, 2026

Data Sources Report a data error